[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576617":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":16,"studyPopulation":17,"armGroups":13,"interventions":13,"overallOfficials":18,"centralContacts":23,"locations":28,"responsibleParty":45,"collaborators":13,"id":47,"slug":13,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":13,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":13,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":13,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":31,"whyStopped":13,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Regina Elena Cancer Institute","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Descriptive analyses","Given the pilot nature of the study, we will only perform descriptive analyses, overexpression or silencing experiments of target genes of the NF-Y\u002Fp53 complex activity. These experiments will indicate the impact on the viability of the organoid of target genes of the NF-Y\u002Fp53 complex activity. All the variables of interest will be summarized through absolute frequencies and percentages, if categorical or through medians and relative range, if continuous.","36 months",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":6,"timePerspective":15,"maskingInfo":13},"PROSPECTIVE","Organoids will allow us to study the function of genes that are targets of the NF-Y\u002Fp53 complex activity. In these organoids, we will perform overexpression and\u002For silencing of these genes and assays of proliferation, invasion and motility. We will also perform functional assays in cocultures of the organoids with PBMCs from the same patients. This could allow the discovery of new pathways that could be targeted by targeted therapy and\u002For immunotherapy. Organoid preparation will be performed from fresh colorectal cancer tissue and liver metastasis following enzymatic digestion. Organoid culture medium and specific organic matrix will be used","Patients with colorectal cancer and synchronous liver metastases who will undergo liver resection surgery",[19],{"name":20,"affiliation":21,"role":22},"Giulia Piaggio, Biologist","IRCCS National Cancer Institute","PRINCIPAL_INVESTIGATOR",[24],{"name":20,"role":25,"phone":26,"phoneExt":13,"email":27},"CONTACT","+39 0652662458","gialia.piaggio@ifo.it",[29],{"facility":30,"status":31,"city":32,"state":13,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"\"Regina Elena\" National Cancer Institute","RECRUITING","Rome","00144","Italy","IT",{"type":37,"coordinates":38},"Point",[39,40],12.51133,41.89193,{"lat":40,"lon":39},[43],{"name":20,"role":25,"phone":26,"phoneExt":13,"email":44},"giulia.piaggio@ifo.it",{"type":46,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100576617",false,"NCT06787625","Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases","Pilot Feasibility Study for the Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases","Inclusion Criteria:\n\n* Patients \\> 18 years\n* Histological and cytological diagnosis of colorectal cancer neoplasia that has developed a liver metastasis\n* Patients who are candidates for surgery for colorectal cancer with liver metastasis\n* Signing of the relevant informed consent form.\n\nExclusion Criteria:\n\n* All exclusion criteria adopted in surgical protocols will be applied to the study","ALL","18 Years",{"count":56,"type":57},10,"ESTIMATED","36 Months","OBSERVATIONAL","Pilot feasibility study for the development of organoids from primary colorectal tumors and synchronous liver metastases, to prepare organoids from primary colorectal tumors and synchronous liver metastases. The organoids will allow us to study the function of genes targeted by the activity of the NF-Y\u002Fp53 complex.",[62],"Colo-rectal Cancer",[64,65],"colororectal cancer","organoids","2025-01-16",{"date":68,"type":69},"2025-01-22","ACTUAL",{"date":71,"type":69},"2024-05-25",{"date":73,"type":57},"2028-05-25",{"name":5,"class":6},1]